What is the African Medicines Agency?
Recommendation
18/19 March 2025
Understanding the Importance of GMP
Register now for ECA's GMP Newsletter
Under the umbrella of the African Union (AU), the African Medicines Agency (AMA) is currently being established. The African Medicines Regulatory Harmonization (AMRH) programme started already back in 2009 as a response to addressing challenges faced by National Medicine Regulatory Authorities (NMRAs) in Africa like non-coherent legislative frameworks, limited capacities and delayed approval decisions. It seeks to enable collaboration among African countries and regions, to help harmonise the regulation and oversight of medicines at Africa-wide level. To date, 27 countries have ratified the AMA treaty, and more AU members are expected to complete the process in the near future.
The AMA is also supported by the European Medicines Agency and the EU Commission. With the European medicines regulatory network (EMRN), support will be given in the following areas:
- pooling resources and coordinating work to regulate medicines,
- reducing administrative burden,
- mobilising experts to support scientific and administrative processes,
- training to reinforce scientific and regulatory expertise.
The EMA has now received a grant of ten million euros from the European Commission to support regulatory systems at national and regional level in Africa.
Source: EMA press release
Related GMP News
19.02.2025API Testing is also relevant for the FDA - Warning letter to Indian Manufacturer
12.02.2025Is "right-sizing" GMP and Compliance (Lean GMP) possible?
12.02.2025Update of Training Material for ICH Q8, Q9 and Q10
05.02.2025European Shortages Monitoring Platform (ESMP) goes live
05.02.2025The ICH Q9 Briefing Package - a Forgotten Document?
23.01.2025FDA proposes Standardized Testing for Asbestos in Talc-Containing Cosmetic Products